All Stories
Featured Stories
Evaluating Innovations in Middle Molecule Clearance
Heart, Kidney & Metabolic Care: A Strategic Imperative for Health Systems
SGLT2 Inhibitors Could Play Role in Slowing Kidney Disease Progression
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
-
DaVita Integrated Kidney Care Achieves Three-Year NCQA Population Health Program Accreditation
DaVita IKC’s patient-centered approach helps the organization achieve the Triple Aim—to improve the patient experience of care, improve the health of populations, and to reduce the per capita cost of health care. This has led DaVita IKC to this top performer recognition as an NCQA-accredited provider.
-
Personalized Care Helps Texan with Kidney Disease Live Life to the Fullest
DaVita IKC works with health insurers, providers and health systems to give comprehensive care to people in various stages of kidney disease.
-
Creating a Place Where Everyone Belongs
DaVita’s Village stretches across the world and one way the company helps ensure that it remains strong and vibrant is to support a sense of belonging.
-
A Giving Series: Reach Out and Read
Through DWOG, DaVita teammates elected to donate more than $67,000 to Reach Out and Read.
-
A Giving Series: The American Diabetes Association
This year, DaVita teammates donated more than $75,000 to the ADA’s Health Equity Now Initiative.
